T2DM is characterized by insulin resistance, hyperglycemia, and dyslipidemia (Jaishree and Narsimha, 2020), with oxidative stress being a key contributor to its complications, as reflected by alterations in MDA levels and SOD activity (Xie et al., 2021). This evidence concerns the gene SOD1 and Hyperglycemia.